Instil Bio, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-2.3M | $-3.3M | $968.0K | $62.0K |
| Jun 2020 | $-3.3M | $-3.6M | $275.0K | — |
| Sep 2020 | $-7.2M | $-11.5M | $4.3M | — |
| Mar 2021 | $-17.7M | $-26.9M | $9.1M | $2.8M |
| Jun 2021 | $-32.2M | $-40.7M | $8.5M | — |
| Sep 2021 | $-29.4M | $-51.1M | $21.7M | — |
| Mar 2022 | $-55.1M | $-75.3M | $20.2M | $7.5M |
| Jun 2022 | $-47.3M | $-73.4M | $26.1M | — |
| Sep 2022 | $-40.9M | $-66.1M | $25.2M | — |
| Mar 2023 | $-34.7M | $-43.1M | $8.5M | $4.5M |
| Jun 2023 | $-19.6M | $-26.5M | $7.0M | — |
| Sep 2023 | $-14.4M | $-19.6M | $5.2M | — |
| Mar 2024 | $-14.4M | $-14.4M | $0 | $4.5M |
| Jun 2024 | $-10.6M | $-10.6M | $0 | — |
| Sep 2024 | $-20.1M | $-20.1M | $0 | — |
| Mar 2025 | $-4.2M | $-4.2M | — | $3.5M |
| Jun 2025 | $-14.8M | $-14.8M | — | — |
| Sep 2025 | $-10.6M | $-10.6M | — | — |
| Mar 2026 | $-1.3M | $-1.3M | — | $985.0K |
| Jun 2026 | $-4.6M | $-4.6M | — | — |